Widgetized Section

Go to Admin » Appearance » Widgets » and move Gabfire Widget: Social into that MastheadOverlay zone

Young Males Lagging Behind in HPV Vaccine

Young males lagging behind in HPV vaccinePerhaps it was to be expected, but the high profile reporting regarding the benefits of vaccinating against the human papillomavirus (HPV) vaccine seems to have only reached half the population in the US, ie., females.

Unfortunately, researchers have found that young males are significantly less likely to receive the hpv vaccine than females.

An analysis of data from a statewide survey has revealed that only 14% of males had initiated HPV vaccination compared with 44% for females, based on answers provided by parents of adolescents who completed the 2010 North Carolina Child Health Assessment and Monitoring Program (CHAMP).

Researchers believe that the low level of vaccination amongst young males reflects the lack of information about the vaccine that has been provided to parents, in stark contrast to the efforts made to inform parents of the benefits to young girls.

The researchers noted that reasons for not vaccinating children was substantially gender based, where parents of boys most often cited not getting a recommendation from their health care provider or not knowing that the vaccine was available for boys, while parents of girls most often reported concerns about safety and side effects.

“Our findings underscore the importance of health care provider recommendation of the HPV vaccine,” wrote lead author Melissa B. Gilkey, Ph.D. ”The difference in coverage between sons and daughters in our sample is not surprising, as our study was conducted soon after licensure for males,” they reported.

It’s hoped that new guidelines on HPV vaccination from the Centers for Disease Control and Prevention are likely to increase boys’ access to the HPV vaccine, as private insurers typically cover the cost of vaccines that are recommended for routine use. “However, the experience with girls suggests that achieving widespread coverage among boys will require a concerted effort,” the researchers pointed out.

The importance of vaccinating males against the HPV virus has been underscored by recent research published in The NewEngland Journal of Medicine has found that males who were vaccinated against human papillomavirus developed 75 per cent fewer anal lesions that lead to cancer than their counterparts who were given a placebo.

Meanwhile in Australia, where the uptake of the human papillomavirus (HPV) vaccine amongst girls is at a remarkable 90%, the government has dragged its feet in making the vaccine available to young males, however it is expected to be available from 2013.

The Australian Pharmaceutical Benefits Advisory Committee has recommended the HPV vaccine be given to boys aged 12 to 13 in a school-based program. The committee, in its recently released minutes, also suggested a “catch-up” scheme over two years for Year 9 male students.

The HPV vaccine has been available free to Australian girls aged 12 and 13 since 2007.

Please follow and like us:
Posted by on April 19, 2012. Filed under Health. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

Leave a Reply

Your email address will not be published. Required fields are marked *